Activist Oasis suggests 3 steps to build shareholder value at Kobayashi [Video]

Company: Kobayashi Pharmaceutical (4967.T)

Activist: Oasis Management Company

What’s happening

Oasis recently reported a 5.20% position in Kobayashi. Amid a scandal around Kobayashi’s red koji-related products, Oasis said that it could engage the company if there was no self-improvement and suggested three paths for value creation: (i) Kobayashi could improve operational performance on its own; (ii) go private via a management buyout; or (iii) work with Oasis to improve operational performance, corporate governance and the constitution of the board.

Behind the scenes